1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. Last update 2010. www.goldcopd.org

2. Mannino D.M., Homa D.M., Akinbami L.J. et al. Chronic obstructive pulmonary disease surveillance–United States, 1971–2000. Morbid. Mortal. Wkly Rep. Surveill. Summ. 2002; 51: 1–16.

3. Тилик Т.В., Невзорова В.А., Вахрушева С.Е. и др. Полиморфизм генов глютатионтрансфераз при хронической обструктивной болезни легких, ассоциированной с ишемической болезнью сердца. Pacific Med. J. 2010; 1: 13–15.

4. Hu G., Shi Z., Hu J. et al. Association between polymorphisms of microsomal epoxide hydrolase and COPD: Results from meta$analyses. Respirology 2008; 13: 837–850.

5. Ishii T., Matsuse T., Teramoto S. et al. Glutathione S–transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999; 54 (8): 693–696.

6. He J. –Q., Connet J.E., Anthonisen N.R. et al. Glutathione S–transferase variants and their interaction with smoking on lung function. Am. J. Respir. Crit. Care Med. 2004; 170: 388–394.

7. Rodriguez F., Roza C., Jardi R. et al. Glutathione S–transferase P1 and lung function in patients with α1–antitrypsin deficiency and COPD. Am. J. Respir. Cell Mol. Biol. 2005; 33: 71–78.

8. Cheng S–L., Yu C–J., Chen C–J. et al. Genetic polymorphism of epoxide hydrolase and glutathione S–transferase in COPD. Eur. Respir. J. 2004; 23: 818–824.

9. Chan–Yeung M., Ho S.P., Cheung A.H. et al. Polymorphisms of glutathione S–transferase genes and functional activity in smokers with or without COPD. Int. J. Tuberc. Lung Dis. 2007; 11 (5): 508–514.

10. Ada A.O., Suzen H.S., Iscan M.P. Polymorphisms of microsomal epoxide hydrolase and glutathione S–transferase P1 in a male turkish population. Int. J. Toxicol. 2007; 26: 41–46.

11. Корытина Г.Ф. Анализ полиморфных вариантов генов ферментов антиоксидантной защиты и их связь с развитием хронической обструктивной болезни легких у жителей Республики Башкортостан. Генетика 2009; 45 (7): 967–976.

12. Joos L., Pare P.D., Sandford A.J. Genetic risk factors for chronic obstructive pulmonary disease. Swiss. Med. Wkly 2002; 132: 27–37.

13. Hersh C.P., DeMeo D.L., Lazarus R. et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006; 173: 977–984.

14. Brogger J., Steen V.M., Eiken H.G. et al. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur. Respir. J. 2006; 27: 682–688.